Seite wählen

SIRION Biotech Announces Record First Half 2019 Financial Results

Viral Vector Engineer Gains Momentum from its Technology, LentiBoost™ with 100% Growth July 31, 2019 09:25 AM Eastern Daylight Time MUNICH–(BUSINESS WIRE)–SIRION Biotech GmbH (“SIRION”), a world leader in viral vector-based gene delivery technologies for...

SIRION Biotech Expands US Presence in Massachusetts

Europe’s Leading Commercial Provider of Viral Vector Technology Opens Local Office in Cambridge CAMBRIDGE, Mass.–(BUSINESS WIRE)–SIRION Biotech International Inc., a wholly-owned subsidiary of SIRION Biotech GmbH in Germany (“SIRION”), offering the most...

Dr Carl Christel

Dr. Carl Christel Vice President, US Operations, SIRION Biotech International, Inc.  Phone :+1 (857) 284-1844 A true dual-citizen of American and German descent, Carl has lived and worked as a molecular biologist on both sides of the Atlantic. After receiving his PhD...